AU2024318152A1 - Topical agent for onychomycosis - Google Patents

Topical agent for onychomycosis

Info

Publication number
AU2024318152A1
AU2024318152A1 AU2024318152A AU2024318152A AU2024318152A1 AU 2024318152 A1 AU2024318152 A1 AU 2024318152A1 AU 2024318152 A AU2024318152 A AU 2024318152A AU 2024318152 A AU2024318152 A AU 2024318152A AU 2024318152 A1 AU2024318152 A1 AU 2024318152A1
Authority
AU
Australia
Prior art keywords
solvent
dibasic acid
acid diester
lower alcohol
onychomycosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024318152A
Other languages
English (en)
Inventor
Yutaka Ishibashi
Takaharu Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Publication of AU2024318152A1 publication Critical patent/AU2024318152A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2024318152A 2023-08-02 2024-08-02 Topical agent for onychomycosis Pending AU2024318152A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023125977 2023-08-02
JP2023-125977 2023-08-02
PCT/JP2024/027707 WO2025028651A1 (ja) 2023-08-02 2024-08-02 爪白癬用外用剤

Publications (1)

Publication Number Publication Date
AU2024318152A1 true AU2024318152A1 (en) 2026-02-05

Family

ID=94395367

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2024318152A Pending AU2024318152A1 (en) 2023-08-02 2024-08-02 Topical agent for onychomycosis

Country Status (7)

Country Link
JP (1) JPWO2025028651A1 (https=)
KR (1) KR20260046477A (https=)
CN (1) CN121772922A (https=)
AU (1) AU2024318152A1 (https=)
MX (1) MX2026000870A (https=)
TW (1) TW202519215A (https=)
WO (1) WO2025028651A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007102243A1 (ja) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
MX2020004491A (es) * 2017-10-30 2020-08-13 Kaken Pharma Co Ltd Preparacion externa para tratar tinea unguium.
WO2019150485A1 (ja) * 2018-01-31 2019-08-08 Meiji Seikaファルマ株式会社 爪白癬の予防又は治療用外用液剤
WO2020231800A1 (en) 2019-05-10 2020-11-19 Encube Ethicals Private Limited Topical antifungal formulation
BR112022024702A2 (pt) 2020-06-03 2023-02-28 Ishihara Sangyo Kaisha Agente antifúngico para ser humano
JP7780094B2 (ja) * 2020-06-03 2025-12-04 石原産業株式会社 非ヒト動物用抗菌剤
TW202330476A (zh) 2021-12-08 2023-08-01 日商石原產業股份有限公司 5-氯-4-(3-氯-4-甲基苯基)-1h-咪唑-2-甲腈之水合物結晶

Also Published As

Publication number Publication date
KR20260046477A (ko) 2026-04-07
WO2025028651A1 (ja) 2025-02-06
CN121772922A (zh) 2026-03-31
TW202519215A (zh) 2025-05-16
MX2026000870A (es) 2026-03-02
JPWO2025028651A1 (https=) 2025-02-06

Similar Documents

Publication Publication Date Title
EP3612228B1 (en) Iodine compositions
KR101373955B1 (ko) 외용의 의약 조성물
DE60204322T2 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
EP2452673B1 (en) Chitosan gel for dermatological use, production method therefor and use of same
CN111295202B (zh) 治疗甲癣的外用制剂
EP3556368B1 (en) Onychomycosis therapeutic agent
NZ251783A (en) Antimicrobial compositions comprising monoglyceride of lauric or monomyriotic acid with urea, fusidic acid, econazole nitrate, mikonazole nitrate, tinidazole, metronidazole or petanediol
FI69753B (fi) Foerfarande foer framstaellning av en salva pao basis av isosorbiddinitrat
US10172789B2 (en) Compositions for transdermal delivery of mTOR inhibitors
US20180255781A1 (en) Antimicrobial Composition
JP2014508146A (ja) 抗真菌組成物
KR102272901B1 (ko) 메조-2,3-부탄디올을 방부제로서 함유하는 피부 외용제 조성물
AU2024318152A1 (en) Topical agent for onychomycosis
RU2536252C2 (ru) Новый дерматологический крем, изготовленный с использованием фусидата натрия
KR20060019559A (ko) 소독 및/또는 살균용 수성 조성물
JP4541661B2 (ja) 消毒および/または殺菌用組成物
CA2938922A1 (en) Topical antifungal composition for treating onychomycosis
HK40024555A (en) External preparation for treating trichophytosis unguium
HK40024555B (en) External preparation for treating trichophytosis unguium
JP7116434B2 (ja) メマンチン含有経皮吸収型液剤
Piérard-Franchimont et al. Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences
HK40024598B (en) Iodine compositions
HK40024598A (en) Iodine compositions